ClinicalTrials.Veeva

Menu

Botulinum Toxin Injection in Reducing Scar Following Cheilorrhaphy.

M

Mansoura University

Status

Active, not recruiting

Conditions

Unilateral Cleft Lip

Treatments

Procedure: Modified Millard rotation advancement flap technique
Drug: botulinum toxin injection (BTX A) before surgical intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT07137234
M0101025OS

Details and patient eligibility

About

the aim of the study will be directed to evaluate clinically the effect of botulinum toxin type A injection on reducing the scar following cleft lip surgical repair.

Enrollment

32 patients

Sex

All

Ages

10+ weeks old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

inclusion criteria :

  1. patients with mild to severe unilateral cleft lip requiring repair
  2. free from any systemic disease
  3. with or without cleft palate exclusion criteria :

1- patients with syndromic type of cleft lip 2- patients with systemic disease

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

32 participants in 2 patient groups

Group I : 16 patient with unilateral cleft lip treated with surgical procedure alone
Experimental group
Treatment:
Procedure: Modified Millard rotation advancement flap technique
Group II : 16 patients with unilateral cleft lip treated with botulinum toxin injection and surgery
Experimental group
Treatment:
Drug: botulinum toxin injection (BTX A) before surgical intervention
Procedure: Modified Millard rotation advancement flap technique

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems